Literature DB >> 27432532

The two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis.

Satoko Yamaoka1, Hideki Ebihara1.   

Abstract

Entities:  

Keywords:  Rift Valley fever; differentiate infected from vaccinated animals (DIVA); interferon antagonism; live-attenuated vaccine; nonstructural protein NSs

Mesh：

Substances：

Year:  2016        PMID： 27432532      PMCID： PMC5160437          DOI： 10.1080/21505594.2016.1213938

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  29 in total

1.  Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.

Authors:  Myrna M Miller; Kristine E Bennett; Barbara S Drolet; Robbin Lindsay; James O Mecham; Will K Reeves; Hana M Weingartl; William C Wilson
Journal:  Clin Vaccine Immunol       Date:  2015-06-03

2.  Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.

Authors:  Shoko Nishiyama; Olga A L Slack; Nandadeva Lokugamage; Terence E Hill; Terry L Juelich; Lihong Zhang; Jennifer K Smith; David Perez; Bin Gong; Alexander N Freiberg; Tetsuro Ikegami
Journal:  Virulence       Date:  2016-06-01       Impact factor: 5.882

Review 3.  Rift Valley Fever: An Emerging Mosquito-Borne Disease.

Authors:  Kenneth J Linthicum; Seth C Britch; Assaf Anyamba
Journal:  Annu Rev Entomol       Date:  2016       Impact factor: 19.686

4.  Toscana virus induces interferon although its NSs protein reveals antagonistic activity.

Authors:  Gianni Gori Savellini; Friedemann Weber; Chiara Terrosi; Matthias Habjan; Barbara Martorelli; Maria Grazia Cusi
Journal:  J Gen Virol       Date:  2010-09-22       Impact factor: 3.891

Review 5.  Molecular biology and genetic diversity of Rift Valley fever virus.

Authors:  Tetsuro Ikegami
Journal:  Antiviral Res       Date:  2012-06-16       Impact factor: 5.970

6.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

7.  Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals.

Authors:  Brian H Bird; César G Albariño; Amy L Hartman; Bobbie Rae Erickson; Thomas G Ksiazek; Stuart T Nichol
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

8.  Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.

Authors:  Tetsuro Ikegami; Krishna Narayanan; Sungyong Won; Wataru Kamitani; C J Peters; Shinji Makino
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

Review 9.  Novel approaches to develop Rift Valley fever vaccines.

Authors:  Sabarish V Indran; Tetsuro Ikegami
Journal:  Front Cell Infect Microbiol       Date:  2012-10-26       Impact factor: 5.293

10.  A review of vaccine development and research for industry animals in Korea.

Authors:  Nak-Hyung Lee; Jung-Ah Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  Clin Exp Vaccine Res       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.